1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Concord Drugs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
39.20% Fall from 52W High
3.5
TTM PE Ratio
Negative PE TTM
-73.4
Price to Book Ratio
Low in industry
1.1
Dividend yield 1yr %
0
TTM PEG Ratio
Concord Drugs Ltd Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Concord Drugs Ltd Quarterly Revenue
| Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
12.36 Cr | 11.69 Cr | 15.64 Cr | 12.78 Cr | 7.52 Cr |
Concord Drugs Ltd Yearly Revenue
| Mar 2024 | Mar 2023 |
|---|---|
44.93 Cr | 52.09 Cr |
Concord Drugs Ltd Quarterly Net Profit/Loss
| Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
0.04 Cr | 0.03 Cr | -0.34 Cr | -0.24 Cr | 0.56 Cr |
Concord Drugs Ltd Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 |
|---|---|
0.47 Cr | 0.99 Cr |
Concord Drugs Ltd Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
37.30
10Day EMA
37.20
12Day EMA
37.10
20Day EMA
37.00
26Day EMA
36.90
50Day EMA
36.90
100Day EMA
37.00
200Day EMA
37.20
5Day SMA
37.30
10Day SMA
37.20
20Day SMA
36.80
30Day SMA
36.70
50Day SMA
36.80
100Day SMA
36.70
150Day SMA
37.40
200Day SMA
37.30
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 4004 Rs | 5819 Rs |
Week Rs | 3551 Rs | 4259 Rs |
Month Rs | 6522 Rs | 10075 Rs |
Resistance & Support
37.00
Pivot
Resistance
First Resistance
37.99
Second Resistance
38.60
Third Resistance
39.59
Support
First Support
36.39
Second support
35.40
Third Support
34.79
Relative Strength Index
53.44
Money Flow Index
56.28
MACD
0.20
MACD Signal
0.16
Average True Range
2.03
Average Directional Index
21.39
Rate of Change (21)
4.62
Rate of Change (125)
-4.08
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Veerhealth Care Ltd. | - | - | - | |
Phaarmasia Ltd. | - | - | - | |
Bacil Pharma Ltd. | - | - | - | |
Zenith Healthcare Ltd. | - | - | - | |
Concord Drugs Ltd. | - | - | - | |
Gujarat Inject (Kerala) Ltd. | - | - | - | |
Walpar Nutritions Ltd. | - | - | - |
Concord Drugs Ltd Company background
Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Concord Drugs Ltd FAQs
How can I buy Concord Drugs Ltd shares?
You can easily buy Concord Drugs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
